Effect of renal sympathetic nerve on adrenergically and angiotensin II-induced renal vasoconstriction in normal Wistar-Kyoto rats

References

• Marano G, Argiolas L. Postjunctional regulation by angiotensin II of alpha 1-adrenoceptor-mediated pressor responses in the rat. Eur J Pharmacol. 1994;261:121–6.
   PubMed Web of Science ®Google Scholar
• Raasch W, Dominiak P, Ziegler A, Dendorfer A. Reduction of vascular noradrenaline sensitivity by AT1 antagonists depends on functional sympathetic innervation. Hypertension. 2004;44:346–51.
   Google Scholar
• Chen K, Zimmerman BG. Angiotensin II-mediated renal vasoconstriction amenable to alpha 1-adrenoceptor blockade. Eur J Pharmacol. 1995;284:281–8.
   Google Scholar
• DiBona GF. Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension. 2000;36:1083–8.
   Google Scholar
• Holmer SR, Kaissling B, Putnik K, Pfeifer M, Kramer BK, Riegger GA, Beta-adrenergic stimulation of renin expression in vivo. J Hypertens. 1997;15:1471–9.
   Google Scholar
• Vatta MS, Bianciotti LG, Locatelli AS, Papouchado ML, Fernandez BE. Monophasic and biphasic effects of angiotensin II and III on norepinephrine uptake and release in rat adrenal medulla. Can J Physiol Pharmacol. 1992;70:821–5.
   PubMed Web of Science ®Google Scholar
• Abdulla MH, Sattar MA, Khan MA, Abdullah NA, Johns EJ. Influence of sympathetic and AT-receptor blockade on angiotensin II and adrenergic agonist-induced renal vasoconstrictions in spontaneously hypertensive rats. Acta Physiol (Oxf). 2009;195:397–404.
   PubMedGoogle Scholar
• Rodriguez Perez JC, Cabrera JJ, Anabitarte A, Plaza ML, Losada A, Garcia Suarez P, [Effects of carvedilol in rats with induced chronic kidney failure]. Nefrologia. 2001;21:52–8.
   Google Scholar
• Rodriguez-Perez JC, Losada A, Anabitarte A, Cabrera J, Llobet J, Palop L, Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats. J Pharmacol Exp Ther. 1997;283:336–44.
   Google Scholar
• Bayorh MA, Ganafa AA, Eatman D, Walton M, Feuerstein GZ. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension. Am J Hypertens. 2005;18:1496–502.
   PubMed Web of Science ®Google Scholar
• Abdulla MH, Sattar MA, Abdullah NA, Khan MA, Abdallah HH, Johns EJ. Chronic treatment with losartan and carvedilol differentially modulates renal vascular responses to sympathomimetics compared to treatment with individual agents in normal Wistar Kyoto and spontaneously hypertensive rats. Eur J Pharmacol. 2009;612:69–74.
   Google Scholar
• Abdulla MH, Sattar MA, Salman IM, Abdullah NA, Ameer OZ, Khan MA, Effect of acute unilateral renal denervation on renal hemodynamics in spontaneously hypertensive rats. Auton Autacoid Pharmacol. 2008;28:87–94.
   Google Scholar
• Abdulla MH, Sattar MA, Abdullah NA, Hazim AI, Anand Swarup KR, Rathore HA, Inhibition of Ang II and renal sympathetic nerve influence dopamine- and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats. Auton Autacoid Pharmacol. 2008;28:95–101.
   Google Scholar
• Hye Khan MA, Sattar MA, Abdullah NA, Johns EJ. Influence of combined hypertension and renal failure on functional alpha(1)-adrenoceptor subtypes in the rat kidney. Br J Pharmacol. 2008;153:1232–41.
   PubMedGoogle Scholar
• Just A, Olson AJ, Whitten CL, Arendshorst WJ. Superoxide mediates acute renal vasoconstriction produced by angiotensin II and catecholamines by a mechanism independent of nitric oxide. Am J Physiol Heart Circ Physiol. 2007;292:H83–92.
   PubMedGoogle Scholar
• Armenia A, Sattar MA, Abdullah NA, Khan MA, Johns EJ. Functional subtypes of renal alpha1-adrenoceptor in diabetic and non-diabetic 2K1C Goldblatt renovascular hypertension. Acta Pharmacol Sin. 2008;29:564–72.
   Google Scholar
• Khan MA, Sattar MA, Abdullah NA, Johns EJ. Alpha1B-adrenoceptors mediate adrenergically-induced renal vasoconstrictions in rats with renal impairment. Acta Pharmacol Sin. 2008;29:193–203.
   PubMedGoogle Scholar
• Takishita S, Muratani H, Sesoko S, Teruya H, Tozawa M, Fukiyama K, Short-term effects of angiotensin II blockade on renal blood flow and sympathetic activity in awake rats. Hypertension. 1994;24:445–50.
   PubMed Web of Science ®Google Scholar
• Rademacher R, Berecek KH, Ploth DW. Effects of angiotensin inhibition and renal denervation in two-kidney, one clip hypertensive rats. Hypertension. 1986;8:1127–34.
   Google Scholar
• Cleary L, Slattery J, Bexis S, Docherty JR. Sympathectomy reveals alpha 1A- and alpha 1D-adrenoceptor components to contractions to noradrenaline in rat vas deferens. Br J Pharmacol. 2004;143:745–52.
   Google Scholar
• Sumners C, Raizada MK, Kang J, Lu D, Posner P. Receptor-mediated effects of angiotensin II on neurons. Front Neuroendocrinol. 1994;15:203–30.
   Google Scholar
• Balt JC, Mathy MJ, Pfaffendorf M, van Zwieten PA. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats. Fundam Clin Pharmacol. 2003;17:83–91.
   Google Scholar
• Wong PC, Hart SD, Timmermans PB. Effect of angiotensin II antagonism on canine renal sympathetic nerve function. Hypertension. 1991;17:1127–34.
   Google Scholar
• Wong PC, Bernard R, Timmermans PB. Effect of blocking angiotensin II receptor subtype on rat sympathetic nerve function. Hypertension. 1992;19:663–7.
   PubMed Web of Science ®Google Scholar
• Hu ZW, Shi XY, Okazaki M, Hoffman BB. Angiotensin II induces transcription and expression of alpha 1-adrenergic receptors in vascular smooth muscle cells. Am J Physiol. 1995;268:H1006–14.
   Google Scholar
• Batenburg WW, van Esch JH, Garrelds IM, Jorde U, Lamers JM, Dekkers DH, Carvedilol-induced antagonism of angiotensin II: a matter of alpha1-adrenoceptor blockade. J Hypertens. 2006;24:1355–63.
   PubMed Web of Science ®Google Scholar